Synthetic Biologics Names Dr. Mark Pimentel Chairman of IBS Advisory Board

Synthetic Biologics appointed gastroenterologist Mark Pimentel, MD, chairman of its new irritable bowel syndrome clinical advisory board.

Advertisement

The advisory board will serve to support the development of the company’s constipation-predominant IBS program. Dr. Pimentel led the team whose discoveries form the foundation of the C-IBS program.

Dr. Pimentel is an associate professor of medicine at Cedars-Sinai Medical Center in Los Angles.

More Articles on Gastroenterology:
CO2 Insufflation vs. Air Insufflation in Enteroscopy
The Best Opportunities for Quality Improvement Projects in Gastroenterology
Are More Gastroenterologists Participating in ACOs?

Advertisement

Next Up in GI & Endoscopy

  • The MUSC Shawn Jenkins Children’s Hospital in Charleston, S.C., has launched the MUSC Advanced Pediatric Endoscopy Program and Pancreas Center. …

  • For GI clinics and ASCs, accurate coding and documentation are critical to protecting reimbursement, reducing denials and withstanding payer audits. …

Advertisement

Comments are closed.